Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386630153> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- W4386630153 abstract "Patients with immune-mediated inflammatory diseases, such as rheumatic diseases or inflammatory bowel disease are commonly treated with a type of medicine called Tumour Necrosis Factor (TNF) α inhibitors. The therapeutic effect of these TNFα inhibitors can vary between patients. Thus, patients often need to switch to a different treatment. In our thesis we showed that about 17% of IMID patients switch treatment, mainly due to loss of effect. As TNFα inhibitors are costly therapies, transitioning patients to a biosimilar (different brand name, same active ingredient), is a good option for cost containment. We found that several European medical associations have guidelines on transitioning patients from the original TNFα inhibitor (originator) to biosimilar. We found that one in six patients who transitioned from originator TNFα inhibitor to the biosimilar subsequently retransitioned to the originator (stopped biosimilar and restarted originator). Despite originators and biosimilars being similar in terms of efficacy and safety, these patients experienced loss of therapeutic effect and/or side effects from the biosimilar. We found that several factors might affect the number of patients retransitioning, such as the disease severity of the patients and extra monitoring to patients during transitioning. Patients who retransitioned had a more than threefold risk of stopping their originator treatment, indicating that they are still not satisfactorily treated after retransitioning. Patients mentioned that they missed autonomy in transitioning to the biosimilar, and they felt like their hospital prioritised finances over their wellbeing. These findings provide several strategies for improving biosimilar implementation in clinical practice, such as careful selection of a biosimilar, increasing trust in biosimilars, providing follow-up care to transitioned patients and accepting a certain proportion of patients retransitioning." @default.
- W4386630153 created "2023-09-13" @default.
- W4386630153 creator A5085745569 @default.
- W4386630153 date "2023-09-12" @default.
- W4386630153 modified "2023-10-18" @default.
- W4386630153 title "TNFα inhibitor treatment trajectories" @default.
- W4386630153 doi "https://doi.org/10.33540/1837" @default.
- W4386630153 hasPublicationYear "2023" @default.
- W4386630153 type Work @default.
- W4386630153 citedByCount "0" @default.
- W4386630153 crossrefType "dissertation" @default.
- W4386630153 hasAuthorship W4386630153A5085745569 @default.
- W4386630153 hasConcept C126322002 @default.
- W4386630153 hasConcept C177713679 @default.
- W4386630153 hasConcept C17991360 @default.
- W4386630153 hasConcept C2778260677 @default.
- W4386630153 hasConcept C2779134260 @default.
- W4386630153 hasConcept C59491497 @default.
- W4386630153 hasConcept C71924100 @default.
- W4386630153 hasConceptScore W4386630153C126322002 @default.
- W4386630153 hasConceptScore W4386630153C177713679 @default.
- W4386630153 hasConceptScore W4386630153C17991360 @default.
- W4386630153 hasConceptScore W4386630153C2778260677 @default.
- W4386630153 hasConceptScore W4386630153C2779134260 @default.
- W4386630153 hasConceptScore W4386630153C59491497 @default.
- W4386630153 hasConceptScore W4386630153C71924100 @default.
- W4386630153 hasLocation W43866301531 @default.
- W4386630153 hasOpenAccess W4386630153 @default.
- W4386630153 hasPrimaryLocation W43866301531 @default.
- W4386630153 hasRelatedWork W1560551965 @default.
- W4386630153 hasRelatedWork W2912734254 @default.
- W4386630153 hasRelatedWork W2955056766 @default.
- W4386630153 hasRelatedWork W3028339715 @default.
- W4386630153 hasRelatedWork W3159932183 @default.
- W4386630153 hasRelatedWork W4220693647 @default.
- W4386630153 hasRelatedWork W4231136064 @default.
- W4386630153 hasRelatedWork W4362578247 @default.
- W4386630153 hasRelatedWork W4362580351 @default.
- W4386630153 hasRelatedWork W4380154544 @default.
- W4386630153 isParatext "false" @default.
- W4386630153 isRetracted "false" @default.
- W4386630153 workType "dissertation" @default.